Business Combinations (Tables)

12 Months Ended

Dec. 31, 2014

The aggregate amounts of revenue and net income of ForwardThink, BioPharm, and Trifecta included in the Company's Consolidated Statements of Operations from the respective acquisition dates to December 31, 2014 are as follows (in thousands):

	Acquisition Date to December 31, 2014
Revenues	$	48,108
Net income	$	4,917

Pro-Forma Results of Operations (Unaudited)

The following presents the unaudited pro-forma combined results of operations of the Company with ForwardThink, BioPharm, and Trifecta for the year ended December 31, 2014 and TriTek, Clear Task, CoreMatrix, ForwardThink, BioPharm, and Trifecta for the year ended December 31, 2013, after giving effect to certain pro-forma adjustments related to the amortization of acquired intangible assets and assuming ForwardThink, BioPharm, and Trifecta were acquired as of the beginning of 2013 and TriTek, Clear Task, and CoreMatrix were acquired as of the beginning of 2012. These unaudited pro-forma results are presented in compliance with the adoption of ASU 2010-29, Business Combinations (Topic 805): Disclosure of Supplementary Pro Forma Information for Business Combinations, and are not necessarily indicative of the actual consolidated results of operations had the acquisitions actually occurred on January 1, 2013 or January 1, 2012 or of future results of operations of the consolidated entities (in thousands except per share data):

	December 31,
	2014		2013
Revenues	$	467,825	$	452,036
Net income	$	27,544	$	26,986
Basic net income per share	$	0.84	$	0.84
Diluted net income per share	$	0.83	$	0.81
Shares used in computing basic net income per share		32,736		31,990
Shares used in computing diluted net income per share		33,350		33,304

TriTek [Member]

Business Acquisition [Line Items]

Allocation Of The Total Purchase Price Consideration

The Company allocated the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	11.9
Acquired intangible assets		6.2
Liabilities assumed		(6.1	)
Goodwill		9.1
Total purchase price	$	21.1

ClearTask [Member]

Business Acquisition [Line Items]

Allocation Of The Total Purchase Price Consideration

The Company allocated the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	2.1
Acquired intangible assets		1.6
Liabilities assumed		(0.8	)
Goodwill		5.7
Total purchase price	$	8.6

CoreMatrix [Member]

Business Acquisition [Line Items]

Allocation Of The Total Purchase Price Consideration

The Company allocated the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	3.6
Acquired intangible assets		4.8
Liabilities assumed		(1.5	)
Goodwill		17.6
Total purchase price	$	24.5

ForwardThink [Member]

Business Acquisition [Line Items]

Allocation Of The Total Purchase Price Consideration

The Company has estimated the allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	4.5
Acquired intangible assets		18.0
Liabilities assumed		(11.9	)
Goodwill		29.5
Total purchase price	$	40.1

BioPharm [Member]

Business Acquisition [Line Items]

Allocation Of The Total Purchase Price Consideration

The Company has estimated the allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	3.4
Acquired intangible assets		8.4
Liabilities assumed		(1.2	)
Goodwill		5.7
Total purchase price	$	16.3

Trifecta [Member]

Business Acquisition [Line Items]

Allocation Of The Total Purchase Price Consideration

The Company has estimated the allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

Acquired tangible assets	$	1.6
Acquired intangible assets		5.2
Liabilities assumed		(5.7	)
Goodwill		7.1
Total purchase price	$	8.2